Cite
Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
MLA
McClung, Michael, et al. “Intravenous Zoledronic Acid 5 Mg in the Treatment of Postmenopausal Women with Low Bone Density Previously Treated with Alendronate.” BONE, vol. 41, no. 1, July 2007, pp. 122–28. EBSCOhost, https://doi.org/10.1016/j.bone.2007.03.011.
APA
McClung, M., Recker, R., Miller, P., Fiske, D., Minkoff, J., Kriegman, A., Zhou, W., Adera, M., & Davis, J. (2007). Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate. BONE, 41(1), 122–128. https://doi.org/10.1016/j.bone.2007.03.011
Chicago
McClung, Michael, Robert Recker, Paul Miller, Darrell Fiske, Jerome Minkoff, Audrey Kriegman, Wenchun Zhou, Mathews Adera, and Jenny Davis. 2007. “Intravenous Zoledronic Acid 5 Mg in the Treatment of Postmenopausal Women with Low Bone Density Previously Treated with Alendronate.” BONE 41 (1): 122–28. doi:10.1016/j.bone.2007.03.011.